Objective The outcomes of patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are poor. However. the risk factors for relapse in this context remain unclear. Methods We retrospectively assessed 84 consecutive adult AML patients who underwent allo-HSCT and achieved complete remission (CR). https://parisnaturalfoodes.shop/product-category/fenugreek-blessed-thistle-2/